Conference Coverage

Psoriatic arthritis treatment: “We’re not doing so well”


 

EXPERT ANALYSIS FROM RWCS 2018

Pages

Recommended Reading

Make a PEST of your psoriasis patients
MDedge Dermatology
CV risk factors go undiagnosed, untreated in many psoriatic patients
MDedge Dermatology
Get ready for certolizumab for psoriasis
MDedge Dermatology
Here comes bimekizumab, the newest IL-17 inhibitor
MDedge Dermatology
Risankizumab outpaced ustekinumab for complete clearance of plaque psoriasis
MDedge Dermatology
Biologics have best chance of achieving PASI 90 in psoriasis
MDedge Dermatology
Ustekinumab quells aortic inflammation in patients with severe psoriasis
MDedge Dermatology
Could guselkumab be a disease-modifying agent in plaque psoriasis?
MDedge Dermatology
VIDEO: PPACMAN aims to advance the combined rheum-derm clinic approach in the community
MDedge Dermatology
Do Psoriasis Patients Engage In Vigorous Physical Activity?
MDedge Dermatology